Back

Elamipretide, a cardiolipin-targeting peptide, decreases mitochondrial oxidant stress in the failing human heart

1 May 2017 (14:27 - 14:33)
Organised by:
Congress Presentation Part of: Rapid Fire 5 - Diagnosis - Pathophysiology - Prognosis Pathophysiology HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

About the speaker

Photo
Doctor Brian Stauffer

University of Colorado Anschutz Medical Campus, Aurora (United States of America)

13 More presentations in this session

Presentation thumbnail
Predictors of left ventricular hypertrophy in hypertensive patients. Data from SEPHAR III study.
Associate Professor R. Darabont (Bucharest, RO)
Abstract Slides Video
Presentation thumbnail
A description of characteristics of very elderly patients newly diagnosed with heart failure: a retrospective population-based cohort study in Sweden
Professor M. Olofsson (Skelleftea, SE)
Abstract Slides Video
Presentation thumbnail
Sex, reverse remodeling and prognosis in chronic systolic heart failure
Doctor A. Aimo (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
The clinical meaning of selected single nucleotide polymorphisms in patients with hypertension and heart failure with preserved and mid-range ejection fraction
Assistant Professor A. Bielecka-Dabrowa (Lodz, PL)
Abstract Slides Video
Presentation thumbnail
Association between troponin I and left ventricular global longitudinal strain in outpatients with heart failure
Doctor J. Jensen (Copenhagen, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Rapid Fire 5 - Diagnosis - Pathophysiology - Prognosis

The Event

Event poster

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

1 May 2017 14:27 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources